Journal ArticleDOI
The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know
TLDR
The purpose of this review is to highlight the added role of MR imaging in the treatment stratification and overall care of patients with endometrial, cervical, or ovarian cancer.Abstract:
Advances in MR imaging techniques, along with the growing role of the radiologist as part of a multidisciplinary treatment-planning team, have become central in tailoring treatment options and frequently lead to modifications in the therapeutic approach in patients with gynecologic malignancies.read more
Citations
More filters
Journal ArticleDOI
The Diagnostic accuracy of transvaginal ultrasonography, magnetic resonance imaging and diffusion weighted image in female patients with endometrial carcinoma
TL;DR: Conventional MRI, diffusion weighted imaging and contrast enhanced MR images are superior to TVUS in patients with endometrial cancer and ADC values help to differentiate between normal and endometrian cancer which may replace MR contrast enhanced images.
Journal ArticleDOI
FIGO et cancer de l’endomètre : le mystère du myomètre
TL;DR: L’interpretation peut etre difficile dans certains cas et une bonne communication entre chirurgien and radiologue est primordiale pour un apport optimal de l’IRM.
Journal ArticleDOI
Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
Fengying Qin,Huiting Pang,Jintao Ma,Mingli Zhao,Xiran Jiang,Rui Tong,Tao Yu,Yahong Luo,Yue Dong +8 more
TL;DR: In this paper, the authors combined clinical prognostic factors and magnetic resonance imaging (MRI) parameters on predicting the prognosis after concurrent chemo-radiotherapy (CCRT) in patients with 2018 International Federation of Gynecology and Obstetrics (FIGO) IIICr stage patients.
Journal ArticleDOI
Role of MRI in Diagnosis of Endometrial Cancer
Lobna Abdelmonem Habib,Mona Mohamed Salaheldin Alhawary,Emad Hamed Abd Eldayem,Ahmed Fathy Abd Alghany +3 more
TL;DR: MR imaging with the aid of contrast enhanced images, diffusion weighted images and ADC mapping, had a great role in diagnosis of endometrial cancer as part of pre-operative assessment for lesion characterization and staging of the disease.
Journal ArticleDOI
The role of imaging in pelvic exenteration for gynecological cancers.
TL;DR: Pelvic exenteration (PE) is one of the most challenging gynecologic oncologic surgeries and is an overriding term for different procedures that entail radical en bloc resection of the female reprod...
References
More filters
Journal ArticleDOI
Cancer statistics, 2010
TL;DR: The American Cancer Society as mentioned in this paper estimated the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from National Center for Health Statistics.
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
DG Pfister,K. K. Ang,D Brizel +2 more
Journal ArticleDOI
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote,Claes G. Tropé,Frédéric Amant,G.B. Kristensen,Tom Ehlen,N Johnson,René H.M. Verheijen,Maria E. L. van der Burg,A. J. Lacave,Pierluigi Benedetti Panici,Gemma G. Kenter,Antonio Casado,Cesar Mendiola,Corneel Coens,Leen Verleye,Gavin Stuart,Sergio Pecorelli,Nicholas Reed +17 more
TL;DR: Neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary debulked surgery followed by chemotherapy as a treatment option for patients with bulky stage IIIC or IV ovarian carcinoma in this study.
Journal ArticleDOI
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Anwar R. Padhani,Guoying Liu,Dow Mu-Koh,Thomas L. Chenevert,Harriet C. Thoeny,Taro Takahara,Andrew Dzik-Jurasz,Brian D. Ross,Marc Van Cauteren,David J. Collins,Dima A. Hammoud,Gordon J. S. Rustin,Bachir Taouli,Peter L. Choyke +13 more
TL;DR: DW-MRI should be tested as an imaging biomarker in the context of well-defined clinical trials, by adding DW-MRI to existing NCI-sponsored trials, particularly those with tissue sampling or survival indicators, and standards for measurement, analysis, and display are needed.